Inhaltsbereich
| 422 Einträge | « ‹ 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 › » |
Seite 4 / 22
 Druckansicht
|
| A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions: initial results. |
| Pinker K, Grabner G, Bogner W, Gruber S, Szomolanyi P, Trattnig S, Heinz-Peer G, Weber M, Fitzal F, Pluschnig U, Rudas M, Helbich T |
| Investigative radiology. 2009 Aug 20. doi: 10.1097/RLI.0b013e3181b4c127 |
| PMID: 19652611 |
| Can galactography-guided stereotactic, 11-gauge, vacuum-assisted breast biopsy of intraductal lesions serve as an alternative to surgical biopsy? |
| Reiner CS, Helbich TH, Rudas M, Ponhold L, Riedl CC, Kropf N, Fuchsjäger MH |
| European radiology. 2011 Apr 4. doi: 10.1007/s00330-009-1502-7 |
| PMID: 19565246 |
| Endocrine therapy plus zoledronic acid in premenopausal breast cancer. |
| Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, Pöstlberger S, Menzel C, Jakesz R, Seifert M, Hubalek M, Bjelic-Radisic V, Samonigg H, Tausch C, Eidtmann H, Steger G, Kwasny W, Dubsky P, Fridrik M, Fitzal F, Stierer M, Rücklinger E, Greil R, Marth C |
| The New England journal of medicine. 2009 Feb 13. pii: 360/7/679. doi: 10.1056/NEJMoa0806285 |
| PMID: 19213681 |
| Incomplete surgical resection of ductal carcinomas in situ results in activation of ERBB2 in residual breast cancer cells. |
| Singer CF, Hudelist G, Fuchs EM, Köstler W, Fink-Retter A, Gschwantler-Kaulich D, Gnant M, Lamm W, Rudas M, Czerwenka K, Kubista E |
| Endocrine-related cancer. 2008 Oct 23. pii: ERC-08-0065. doi: 10.1677/ERC-08-0065 |
| PMID: 18948375 |
| Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy. |
| Gnant M, Mlineritsch B, Luschin-Ebengreuth G, Kainberger F, Kässmann H, Piswanger-Sölkner JC, Seifert M, Ploner F, Menzel C, Dubsky P, Fitzal F, Bjelic-Radisic V, Steger G, Greil R, Marth C, Kubista E, Samonigg H, Wohlmuth P, Mittlböck M, Jakesz R |
| The Lancet. Oncology. 2008 Aug 19. pii: S1470-2045(08)70204-3. doi: 10.1016/S1470-2045(08)70204-3 |
| PMID: 18718815 |
| Intraoperative frozen section analysis for breast-conserving therapy in 1016 patients with breast cancer. |
| Riedl O, Fitzal F, Mader N, Dubsky P, Rudas M, Mittlboeck M, Gnant M, Jakesz R |
| European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2008 Aug 15. pii: S0748-7983(08)00192-3. doi: 10.1016/j.ejso.2008.05.007 |
| PMID: 18706785 |
| The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer. |
| Bartsch R, Mlineritsch B, Gnant M, Niernberger T, Pluschnig U, Greil R, Wenzel C, Sevelda P, Thaler J, Rudas M, Pober M, Zielinski CC, Steger GG |
| Breast cancer research and treatment. 2008 Jul 26. doi: 10.1007/s10549-008-0132-0 |
| PMID: 18661231 |
| Factors influencing the time to development of brain metastases in breast cancer. |
| Fromm S, Bartsch R, Rudas M, de Vries A, Wenzel C, Steger GG, Zielinski CC, Poetter R, Dieckmann K |
| Breast (Edinburgh, Scotland). 2008 May 19. pii: S0960-9776(08)00102-1. doi: 10.1016/j.breast.2008.03.008 |
| PMID: 18486473 |
| Prevalence of pre-malignant and malignant lesions in prophylactic mastectomy specimens of BRCA1 mutation carriers: comparison with a control group. |
| Kroiss R, Winkler V, Kalteis K, Bikas D, Rudas M, Tea M, Fuerhauser C, Muhr D, Cerny H, Glueck S, Petru E, Concin H, Kubista E, Oefner P, Wagner T |
| Journal of cancer research and clinical oncology. 2008 Apr 8. doi: 10.1007/s00432-008-0383-5 |
| PMID: 18392852 |
| Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy. |
| Rudas M, Lehnert M, Huynh A, Jakesz R, Singer C, Lax S, Schippinger W, Dietze O, Greil R, Stiglbauer W, Kwasny W, Grill R, Stierer M, Gnant MF, Filipits M |
| Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Mar 18. pii: 14/6/1767. doi: 10.1158/1078-0432.CCR-07-4122 |
| PMID: 18347178 |
| Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer. |
| Bartsch R, Wenzel C, Gampenrieder SP, Pluschnig U, Altorjai G, Rudas M, Mader RM, Dubsky P, Rottenfusser A, Gnant M, Zielinski CC, Steger GG |
| Cancer chemotherapy and pharmacology. 2008 Feb 7. doi: 10.1007/s00280-008-0682-1 |
| PMID: 18256835 |
| Image quality, lesion detection, and diagnostic efficacy in digital mammography: full-field digital mammography versus computed radiography-based mammography using digital storage phosphor plates. |
| Schueller G, Riedl CC, Mallek R, Eibenberger K, Langenberger H, Kaindl E, Kulinna-Cosentini C, Rudas M, Helbich TH |
| European journal of radiology. 2007 Sep 24. pii: S0720-048X(07)00417-2. doi: 10.1016/j.ejrad.2007.08.016 |
| PMID: 17890036 |
| Capecitabine and trastuzumab in heavily pretreated metastatic breast cancer. |
| Bartsch R, Wenzel C, Altorjai G, Pluschnig U, Rudas M, Mader RM, Gnant M, Zielinski CC, Steger GG |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Aug 6. pii: JCO.2007.11.9776. doi: 10.1200/JCO.2007.11.9776 |
| PMID: 17679724 |
| Her2 and progesterone receptor status are not predictive of response to fulvestrant treatment. |
| Bartsch R, Wenzel C, Altorjai G, Pluschnig U, Mader RM, Gnant M, Jakesz R, Rudas M, Zielinski CC, Steger GG |
| Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Aug 2. pii: 13/15/4435. doi: 10.1158/1078-0432.CCR-06-3050 |
| PMID: 17671127 |
| Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer. |
| Bartsch R, Rottenfusser A, Wenzel C, Dieckmann K, Pluschnig U, Altorjai G, Rudas M, Mader RM, Poetter R, Zielinski CC, Steger GG |
| Journal of neuro-oncology. 2007 Jun 8. doi: 10.1007/s11060-007-9420-5 |
| PMID: 17557136 |
| Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14. |
| Steger GG, Galid A, Gnant M, Mlineritsch B, Lang A, Tausch C, Rudas M, Greil R, Wenzel C, Singer CF, Haid A, Pöstlberger S, Samonigg H, Luschin-Ebengreuth G, Kwasny W, Klug E, Kubista E, Menzel C, Jakesz R |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 May 21. pii: 25/15/2012. doi: 10.1200/JCO.2006.09.1777 |
| PMID: 17513805 |
| Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patients. |
| Fitzal F, Riedl O, Wutzl L, Draxler W, Rudas M, Pluschnig U, Handl-Zeller L, Dubsky P, Bachleitner-Hofmann T, Steger G, Jakesz R, Gnant M |
| Breast cancer research and treatment. 2007 Apr 7. doi: 10.1007/s10549-006-9325-6 |
| PMID: 17417725 |
| Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging. |
| Memarsadeghi M, Riedl CC, Kaneider A, Galid A, Rudas M, Matzek W, Helbich TH |
| Radiology. 2006 Oct 23. pii: 241/2/367. doi: 10.1148/radiol.2412050693 |
| PMID: 17057065 |
| Results from an observational trial with oral vinorelbine and trastuzumab in advanced breast cancer. |
| Bartsch R, Wenzel C, Altorjai G, Pluschnig U, Bachleitner-Hoffmann T, Locker GJ, Rudas M, Mader R, Zielinski CC, Steger GG |
| Breast cancer research and treatment. 2006 Sep 21. doi: 10.1007/s10549-006-9342-5 |
| PMID: 17028979 |
| Intensified local treatment and systemic therapy significantly increase survival in patients with brain metastases from advanced breast cancer - a retrospective analysis. |
| Bartsch R, Fromm S, Rudas M, Wenzel C, Harbauer S, Roessler K, Kitz K, Steger GG, Weitmann HD, Poetter R, Zielinski CC, Dieckmann K |
| Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2006 Sep 7. pii: S0167-8140(06)00359-8. doi: 10.1016/j.radonc.2006.08.001 |
| PMID: 16959347 |
| 422 Einträge | « ‹ 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 › » |
Seite 4 / 22
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
